| 000 | 01579 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513212628.0 | ||
| 264 | 0 | _c20000713 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a1084-9785 | ||
| 024 | 7 |
_a10.1089/cbr.1998.13.351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Donnell, R T | |
| 245 | 0 | 0 |
_aCombined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts. _h[electronic resource] |
| 260 |
_bCancer biotherapy & radiopharmaceuticals _cOct 1998 |
||
| 300 |
_a351-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 |
_aBurkitt Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
| 650 | 0 | 4 | _aRadioimmunotherapy |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aYttrium Radioisotopes _xpharmacokinetics |
| 700 | 1 | _aDeNardo, S J | |
| 700 | 1 | _aMiers, L A | |
| 700 | 1 | _aKukis, D L | |
| 700 | 1 | _aMirick, G R | |
| 700 | 1 | _aKroger, L A | |
| 700 | 1 | _aDeNardo, G L | |
| 773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 13 _gno. 5 _gp. 351-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.1998.13.351 _zAvailable from publisher's website |
| 999 |
_c10802525 _d10802525 |
||